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The incorporation of non-canonical amino acids (ncAAs) into ribosomally synthesized
and post-translationally modified peptides, e.g., nisin from the Gram-positive bacterium
Lactococcus lactis, bears great potential to expand the chemical space of various
antimicrobials. The ncAA Nε-Boc-L-lysine (BocK) was chosen for incorporation into
nisin using the archaeal pyrrolysyl-tRNA synthetase–tRNAPyl pair to establish orthogonal
translation in L. lactis for read-through of in-frame amber stop codons. In parallel,
recombinant nisin production and orthogonal translation were combined in Escherichia
coli cells. Both organisms synthesized bioactive nisin(BocK) variants. Screening of
a nisin amber codon library revealed suitable sites for ncAA incorporation and two
variants displayed high antimicrobial activity. Orthogonal translation in E. coli and L. lactis
presents a promising tool to create new-to-nature nisin derivatives.
Keywords: stop codon suppression, pyrrolysyl-tRNA synthetase, nisin, orthogonal translation system,
antimicrobial peptides, bacteriocin, non-canonical amino acids
INTRODUCTION
Lantibiotics represent a class of peptide antibiotics that shows promising antimicrobial activity
against Gram-positive pathogens, e.g., Staphylococcus aureus or Clostridium difficile (Castiglione
et al., 2007; Bierbaum and Sahl, 2009). The best studied example is nisin, synthesized by the Gram-
positive bacterium Lactococcus lactis. It belongs to the class of RiPPs and is translated as a precursor
comprising a 23 amino acid leader peptide fused to a 34 amino acid core peptide. The leader
serves as a docking station for the modification enzymes, directs the transport of the peptide out
of the cell, and keeps it inactive to prevent activity against the producer strain (Bierbaum and
Sahl, 2009; Ortega et al., 2015). Within the core peptide, specific serine and threonine residues are
dehydrated by the dehydratase NisB to form dehydroalanine (Dha) and dehydrobutyrine (Dhb).
Abbreviations: AMP, antimicrobial peptide; BocK, Nε-Boc-L-lysine; ncAA, non-canonical amino acid; OTS, orthogonal
translation system; PTM, post-translational modification; RBS, ribosome-binding site; RiPP, ribosomally synthesized and
post-translationally modified peptide; SCS, stop codon suppression; WT, wild-type.
Frontiers in Microbiology | www.frontiersin.org 1 April 2018 | Volume 9 | Article 657
fmicb-09-00657 April 4, 2018 Time: 16:14 # 2
Bartholomae et al. Combining OTS and PTM for ncAA-Modified Lantibiotics
In a cyclization reaction catalyzed by the cyclase NisC,
these unusual amino acid derivatives are combined with
the next downstream cysteine to form the five characteristic
(methyl)lanthionine rings which are essential for bioactivity. The
post-translationally modified peptide is transported out of the cell
by the transporter NisT. Finally, the leader peptide is cleaved off
by the membrane-associated protease NisP, to release active nisin
(see Figure 1A for a schematic structure of fully modified active
nisin) (Lubelski et al., 2008).
The main characteristics of all RiPPs are the PTMs.
These are crucial, since an unmodified prepeptide lacks
antimicrobial activity (Arnison et al., 2013). The natural variety
of modifications is tremendous, from simple terminal decapping
to complex ring formation in nisin (Wang, 2012). Complete
chemical synthesis of nisin is feasible, however, since the
molecular structure is highly complex, it suffers from a tedious
multi-step synthesis and low yield (Fukase et al., 1988; Ongey
and Neubauer, 2016). Therefore, in vivo methods for engineering
RiPPs are required.
One promising approach is the incorporation of ncAAs,
since, apart from the 20 standard proteinogenic L-amino acids,
they offer new chemical features to AMPs, e.g., by introducing
fluorinated or photocaged residues (McKay and Finn, 2014;
Zambaldo et al., 2017). Moreover, this approach provides a
whole toolkit of new chemical modifications for AMPs, which
even allows to combine peptides by diverse “click chemistry”
approaches, e.g., the Staudinger ligation (Wang et al., 2015) or
strain-promoted azide-alkyne cycloaddition (SPAAC) (Budisa,
2013; Kim et al., 2016).
The pharmaceutical potential of ncAAs – in form of
free amino acids, as well as a modification of peptides and
FIGURE 1 | (A) Schematic structure of fully modified WT nisin. This form of
the antimicrobial peptide lacks the N-terminal leader, which has been
proteolytically cleaved by NisP, activating the lantibiotic as the last maturation
step. The 34 amino acid peptide is displayed in the conventional numbering
scheme from core peptide position I1 until K34. Black circles represent
canonical amino acids in the one letter code and green filled circles represent
dehydroalanine (Dha) or dehydrobutyrine (Dhb). Blue filled circles depict the
(methyl)lanthionine rings comprising alanine (Ala) or aminobutyric acid (Abu)
with thioether bridges depicted by yellow–orange circles. The analyzed
locations for ncAA incorporation, nisinI4 and nisinK12, are highlighted in red.
(B) Structure of Nε-Boc-L-lysine (BocK), the ncAA utilized in this study.
proteins – has been reviewed recently (Blaskovich, 2016). Various
examples demonstrate the potential of ncAA-modified linear
AMPs. For example, the incorporation of proline analogs into
proline-rich peptides increased their macrophage penetration
potential and their activity against Listeria, Brucella, or
methicillin-resistant S. aureus. Moreover, the stability of the
corresponding AMPs against proteolytic degradation by trypsin
has been improved (Kuriakose et al., 2013). First studies with
nisin revealed a change in its antimicrobial activity if it was
supplemented with either tryptophan- or proline analogs at
different locations by force-feeding (Zhou et al., 2016b; Baumann
et al., 2017). A drawback of this method is the global replacement
of one canonical amino acid by the chosen ncAA in the whole
proteome of the producing cell (Hoesl and Budisa, 2012; Zhou
et al., 2016a; Baumann et al., 2017).
To specifically introduce the ncAA at the desired position
in the protein of interest, we focused on implementing the
SCS method (Wang et al., 2001) in L. lactis. This technology
allows reprogramming the amber stop codon TAG to a sense
codon for the ncAA. Genome analysis revealed TAG to be
the least frequently used stop codon in L. lactis (Gupta
et al., 2004). Consequently, introduction of an OTS which is
based on amber suppression was anticipated to have a low
impact on host cell fitness. As key components, the pyrrolysine
(Pyl) tRNA synthetase and its corresponding tRNA from the
archaeon Methanosarcina mazei [pyrrolysyl-tRNA synthetase
(PylRS)–tRNAPyl] are commonly utilized. This aminoacyl-tRNA
synthetase recognizes its cognate tRNA and naturally charges
it with the 22nd amino acid Pyl, allowing its ribosomal
incorporation into the growing polypeptide chain. This enzyme
is of particular interest in biotechnology because of its high
substrate promiscuity resulting from a relatively unspecific amino
acid recognition by mainly hydrophobic interactions, which
allows incorporation of various new amino acid variants (Wan
et al., 2014; Tharp et al., 2017). Being orthogonal in bacterial and
eukaryotic cells, PylRS is commonly used for incorporation of
ncAAs, not only in Escherichia coli, but also in yeast (Hancock
et al., 2010) and mammalian cells (Mukai et al., 2008). Recently,
SCS was established in Bacillus cereus as the first Gram-positive
organism (Luo et al., 2016) and in Synechococcus elongatus as the
first photoautotrophic cyanobacterium (Chemla et al., 2017).
In this study, a double tracked approach toward ncAA-
modified nisin was followed: First, E. coli was equipped with
both the SCS and nisin biosynthesis machineries for recombinant
production of nisin modified with Nε-Boc-L-lysine (BocK) as
chosen ncAA (Figure 1B). Second, the genetic code of L. lactis,
the Gram-positive native nisin production host, was expanded
by introducing the PylRS–tRNAPyl pair to enable SCS. Following
site-specific incorporation of BocK into different locations of
nisin in vivo, the effects on the antimicrobial activity of nisin were
analyzed.
MATERIALS AND METHODS
Bacterial strains, plasmids, and oligonucleotides are described
in Supplementary Tables S1 and S2. Experiments on ncAA
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incorporation were independently conducted at least twice in
order to ensure the reproducibility of the data.
Generation of an Amber Codon-Scanned
Library of nisA
An amber codon-scanned library of nisA with all sense codons
of the core peptide individually replaced by TAG was generated
via multiple parallel overlap extension PCR reactions (Ho
et al., 1989). A synthetic construct pET-21a_P_His6_leader_nisA
served as a template. This construct contains the WT sequence
of nisA (GenBank: HM219853.1) together with an N-terminal
His-tag fused by a small linker to the coding sequence (complete
encoded amino acid sequence: MGSSHHHHHHSQDP). Primers
used for the generation of the library are listed in Supplementary
Table S2. The individual nisA(amber) variants were cloned
via NdeI and XhoI restriction sites into the expression vector
pET-21a (Merck).
For expression in E. coli, selected variants from the
nisA(amber) library (flanked by a T7 promoter and terminator)
were PCR-amplified with the primers PT7-NisA_f and NisA
T7term_r. Purified PCR products were cloned using SpeI and
PstI into pJZ_Ptrp_pylT_strep-MmPylS(Y384F) treated with
XbaI and PstI to yield pJZ_Ptrp_pylT_MmPylS(Y384F) PT7
nisA(amber). In order to combine PTM and SCS for the
production of ncAA-modified nisin variants, BL21(DE3) cells
were co-transformed with the latter plasmid and pRSFDuet-1
nisBC.
To express tRNAPyl and PylRS in L. lactis, pylTS were
amplified from plasmid pJZ_Ptrp_pylT_strep-MmPylS(Y384F)
with the primers PylTSfwNco and PylTSrevKpn. The PCR
product and the vector pLG1RBS-GFP were digested with
the restriction enzymes NcoI and KpnI and ligated, resulting
in vector pNZ-RBSpylTS. Subsequently, selected nisA(amber)
variants were amplified by the primer pair NisLibraryfwKpn
and NisLibraryrevXba. The resulting PCR products and the
vector pNZ-RBSpylTS were digested by KpnI and XbaI,
and the fragments were assembled to form plasmid pNZ-
RBSpylTSnisA(amber). To synthesize the nisA WT control, the
amber codon of pET-21a_P_His6_leader_nisA(K34amber) was
replaced by the WT lysine codon using the mutagenesis primer
NisAWTrevXba, while as forward primer NisLibraryfwKpn was
utilized. The further cloning procedure was identical and resulted
in the plasmid pNZ-RBSpylTSnisA. To enable the PTMs of
the nisin precursor (dehydration and cyclization followed by
transport out of the cell), L. lactis NZ9000 pIL3EryBTC encoding
the modification enzymes NisBTC was transformed by the nisA
plasmid constructs.
Production of ncAA-Containing Nisin
Variants in E. coli
Precultures of E. coli BL21(DE3) pJZ_Ptrp_pylT_MmPylS
(Y384F) PT7 nisA(amber) pRSFDuet-1 nisBC were grown
at 37◦C in LB medium supplemented with antibiotics and
1% w/v glucose. Target gene expression was conducted at
27.5◦C overnight in autoinducing ZYP-5052 medium (Studier,
2005) supplemented with antibiotics. Next, bacterial cells were
harvested by centrifugation. Purification of nisin variants was
conducted as described earlier using an N-terminally His-tagged
peptide leader and Ni-NTA affinity columns (Baumann et al.,
2017).
Preparation of Nisin Variants Modified
by ncAAs from L. lactis
Lactococcus lactis NZ9000 pNZ-RBSpylTSnisA(amber)
pIL3EryBTC was grown in CDM medium (containing 5 µg/ml
each chloramphenicol and erythromycin) to an OD600 of 0.4.
Overexpression was induced with 10 ng/ml nisin and the
medium was supplemented with 1-5 mM Nε-Boc-L-lysine
(BocK) to grow for another 3 h. After harvesting, the supernatant
was filtered, acidified, and finally purified by ion exchange
chromatography using a 5 ml HiTrap SP-Sepharose (GE
Healthcare) column. Fractions showing antimicrobial activity
were pooled, desalted, and finally freeze-dried. For HPLC
purification on an Agilent 1260 Infinity LC instrument, samples
showing antimicrobial activity were desalted with a Sephadex
G10 column (GE Healthcare) and applied to a C12 column
(Phenomenex 250 × 4.5 mm, 4 µm, Proteo 90Å) as described
earlier (Zhou et al., 2016b).
Agar Well Diffusion Assay
To determine the antimicrobial activity of nisin and ncAA-
modified nisin(BocK) variants synthesized by L. lactis, solid
medium was inoculated with 100 µl of nisin-sensitive L. lactis
NZ9000 pNZnisPT pIL253 overnight culture. The first plasmid
(pNZnisPT) leads to expression of NisP, which can activate the
nisin variants later added to the agar by proteolytic cleavage
of the leader peptide. Plasmid pIL253 is an “empty” control
plasmid conferring erythromycin resistance, thus avoiding
growth inhibition from potential carryover of the antibiotic from
the L. lactis production strain supernatant. Fifty microliters of
either filtered culture supernatant or HPLC-purified peptides
was applied to the testing wells (diameter: 7.5 mm) and
incubated at 30◦C overnight, until inhibition halos were
visible.
For nisin variants produced by E. coli, antimicrobial activity
tests were conducted as described (Baumann et al., 2017),
using the same nisin-sensitive and NisP-expressing L. lactis
indicator strain. Briefly, cell lysates produced from 1 ml bacterial
culture were normalized by harvested cell density (OD600)
using PBS buffer. Alternatively, peptide samples purified by
immobilized metal ion affinity chromatography (IMAC) were
used. Chloramphenicol at 400 µg/ml was used as antibacterial
control compound.
Mass Spectrometry
For MALDI–TOF–MS analysis, 1 µl of HPLC-purified sample
was applied to the matrix target and treated as described earlier
on a Voyager DE Pro MALDI-TOF spectrometer (Applied
Biosystems) (van Heel et al., 2013). Data analysis was carried
out with “Data Explorer” software version 4.0.0.0 (Applied
Biosystems). Calculation of theoretical masses with ncAA-
modified nisin variants was carried out with “massXpert”, version
3.4.0 (Rusconi, 2009).
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For LC–ESI–TOF–MS analysis, IMAC-purified samples were
analyzed using a QTOF 6530 instrument (Agilent) as described
(Baumann et al., 2017).
Immunoblotting
Pyrrolysyl-tRNA synthetase expression was verified via an added
N-terminal Strep-tag. After cell growth and harvesting, cell
pellets were dissolved in PBS buffer (58 mM Na2HPO4, 17 mM
NaH2PO4, 68 mM NaCl) and ruptured by bead-beating as
described earlier (Neves et al., 2010). Strep-PylRS was purified
with Strep-Tactin R© Resin (IBA). Fractions containing PylRS were
selected by SDS-Page and verified by immunoblotting with a
1:100 diluted Strep-Tactin HRP (IBA) conjugate according to
manufacturer information. HRP activity was detected using the
Amersham ECL Prime Western Blotting Kit (GE Healthcare).
RESULTS
Combining Stop Codon Suppression
(SCS) and Production of Post-
translationally Modified Nisin in E. coli
In a previous study, recombinant production of fully
modified nisin was established in E. coli (Shi et al., 2011).
Based on this data, we constructed a T7 promoter-based
setup for the recombinant expression of nisABC. The
expression of nisA, nisBC, and pylTS from three different
plasmids revealed to be a significant metabolic burden for
the BL21(DE3) host cells, resulting in slow growth and a
low final optical density of the cultures (data not shown).
Thus, we reduced the number of required plasmids by
introducing nisA(amber) variants into the OTS plasmid
yielding pJZ_Ptrp_pylT_MmPylS(Y384F) PT7 nisA(amber).
We decided to explore a full amber scanning library, which
displays in-frame amber stop codons successively replacing
each of the sense codons of the nisin core peptide, to allow for
identification of variants with efficient SCS and retaining activity.
Following plasmid construction, E. coli was co-transformed
by the individual library member plasmids and a compatible
second plasmid for NisBC co-expression. The latter two
PTM enzymes catalyze the dehydration and circularization
of the nisin precursor peptide (Lubelski et al., 2008). Using
autoinduction medium, nisABC expression was driven by the
T7 promoter system, whereas OTS expression (pylTS) was
constitutive.
Following recombinant expression of pylTS and nisABC in
E. coli, conducted both in presence and in absence of BocK
(Figure 1B), the cell lysates were examined for antimicrobial
activity. For this, the nisin-sensitive NisPT-expressing L. lactis
strain NZ9000 pNZnisPT pIL253 (Khusainov et al., 2011)
was used, which is an indicator strain capable to cleave the
leader peptide to yield fully mature active nisin. Although
mature WT nisin is ineffective against the Gram-negative
bacterium E. coli (Helander and Mattila-Sandholm, 2000), a
nisA leader carrying an N-terminal His-tag was utilized in
order to facilitate purification of the produced peptides. This
modification does not influence the removal of the leader peptide,
since the WT NisP cleavage sequence ASPR | IT remains
intact (Plat et al., 2011; Lagedroste et al., 2017; Montalban-
Lopez et al., 2018). Screening of the amber-scanned nisA
library was performed. Targeting residues corresponding to the
first two rings in the mature lantibiotic (i.e., I1 until K12,
compare Figure 1A) revealed promising candidates, where
ncAA-dependent antimicrobial activity was observed. Distinct
inhibition of microbial growth was observed for samples
corresponding to nisin(I4BocK) and nisin(K12BocK), whereas
very low or no inhibition, respectively, took place in absence of
ncAA supplementation (Figure 2A). Noteworthy, SCS at most
positions within the prepeptide did not result in bioactivity
(Supplementary Figure S2). With no or little change upon ncAA
(BocK) addition, activity was also observed when the amber stop
codon was placed close to the 3′-end of nisA, as shown for
the penultimate prepeptide position in construct nisA(S33amber)
(Supplementary Figure S2). The latter is in line with observations
made from production of modified/truncated variants in L. lactis:
also those truncated prepeptides become processed by NisBC
in vivo and attain detectable levels of antimicrobial activity (Rink
et al., 2007).
Next, ncAA-modified peptides were purified via IMAC,
utilizing the N-terminally His-tagged nisin leader. For both
the WT nisin as control and the SCS samples, antimicrobial
activity was detected from elution fractions and concentration
of bioactive nisin was evident as judged from the size of
inhibition halos (Supplementary Figure S3A). Consequently,
IMAC purification yielded samples of improved purity and
antimicrobial activity. LC–MS analysis was conducted to verify
incorporation of the ncAA into the RiPP. Likewise, the
WT construct without an in-frame amber stop codon was
recombinantly produced, purified, and analyzed. As anticipated,
purified peptide fractions were found to contain NisBC-
processed [i.e., (Me)Lan-containing, cyclized] nisin, for the SCS
samples carrying BocK at positions 4 and 12, respectively (see
Figure 2B and Supplementary Figure S3B for theoretical and
observed molecular masses).
Following established procedures, efforts were made
to quantify and optimize ncAA-containing nisin variant
production. Via Coomassie-stained PAGE, it was observed that
peptide quantities and purities were lower than reported earlier
(Shi et al., 2011) (data not shown). Yields of recombinant
production were reduced upon ncAA incorporation as
commonly is the case for SCS (Zheng et al., 2016). It should be
noted that recombinant production and SCS were performed
in a release factor-1 (RF-1) positive E. coli B laboratory strain
[BL21(DE3)], where amber SCS competes with translation
termination. Nevertheless, the PylRS-based system can deliver
efficient amber suppression in this strain as long as a single
in-frame stop codon is used (Odoi et al., 2013). Furthermore,
E. coli BL21(DE3) was chosen as it grows robustly to high
cell density in the nisin biosynthesis setup (data not shown).
Despite the genetic complexity of the system, the feasibility
of recombinant ncAA-containing nisin production was
demonstrated. Employing the WT L. lactis PTM enzymes
for prepeptide processing, positions were identified to allow
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FIGURE 2 | Antimicrobial activity assay and LC–MS analysis of ncAA-modified nisin produced by SCS in E. coli. (A) Antimicrobial activity of recombinantly produced
nisin variants against the nisin-sensitive indicator strain L. lactis NZ9000 pNZnisPT pIL253 (this strain expresses NisP, which catalyzes removal of the nisin leader
peptide). As indicated, recombinant expression of both nisA(amber) variants was conducted in presence or in absence of BocK. Fifty microliters of E. coli cell lysate
normalized by harvested cell density was used. Cm served as antimicrobial control compound. (B) ESI–MS deconvolution chromatogram for nisin(I4BocK) and
nisin(K12BocK) samples purified via IMAC. Theoretical [M+Na]+ masses for the ncAA-modified prepeptides (still carrying the leader) after PTM by NisBC are 7428.46
and 7413.45 Da, respectively. Observed masses: 7428.40 and 7413.47 Da. Chromatogram shown for nisin(I4BocK), see Supplementary Figure S3B for that of
nisin(K12BocK).
for BocK incorporation into nisin – leading to novel bioactive
ncAA-modified RiPPs. Since nisin(I4BocK) and nisin(K12BocK)
represented reasonable antimicrobial activity, they were chosen
as candidates to transfer this OTS into the natural production
host of nisin, L. lactis.
Modification of PnisA Enables SCS by
PylRS–tRNAPyl Expression in L. lactis
Establishing a functional PylRS-based OTS in L. lactis by
utilization of the NICE system (Kuipers et al., 1998) required
a modification of the nisin inducible promoter PnisA. The
ribosomal-binding site (RBS) located within the WT PnisA was
disrupted by mutating the sequence AAGGAG to AATTCG
(van Gijtenbeek et al., 2016) to hinder unwanted translation of
pylT encoding the orthogonal tRNA. As depicted in Figure 3A,
an additional RBS was added upstream of pylS as well as of
nisA(amber). Despite these genetic rearrangements, the new
variant of PnisA remained functional, because expression of
N-terminally Strep-tagged PylRS was detectable by Streptactin
immunoblotting. After induction of PylRS expression by nisin,
cell extracts of L. lactis NZ9000 pNZ-RBSpylTS and pNZ-
RBSpylTSnisA as well as the empty vector pNZ-RBS as negative
control were applied to a Streptactin column. After purification,
immunoblotting revealed a band of matching molecular weight
by a Streptactin HRP conjugate in elution fractions resulting from
PylRS expressing cells in contrast to cells bearing the control
vector (Figure 3B).
Nisin Bearing ncAAs
With inducible PylRS expression confirmed, the functionality
of PylRS–tRNAPyl in L. lactis was determined with a GFP
amber suppression reporter. The detailed experimental setup is
available in the Supplementary Material, Section 1. In short, the
fluorescence of the GFP variants produced in the presence and
absence of BocK was determined by FACS and compared to cells
expressing WT GFP as positive control and cells expressing only
PylRS–tRNAPyl as negative control. The experiments revealed a
small, but reproducible increase of the intact cell fluorescence in
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FIGURE 3 | Modification of the nisin promoter PnisA for combined OTS and
nisin expression in L. lactis. (A) Modified PnisA (black arrow) of vector
pNZ-RBSpylTS and its derivatives with deleted RBS upstream of pylT
(encoding tRNAPyl) to prevent initiation of translation. RBS locations are
indicated by orange triangles, the original RBS location is crossed out. In blue
arrows, the components of the OTS, pylT and pylS are depicted. The green
arrow labeled with nisA∗ represents the nisin precursor gene, either encoding
the WT (nisA) or variants with in-frame stop codons [nisA(amber)]. The size of
the depicted genes is not drawn to scale. (B) Heterologous expression of
archaeal PylRS controlled by modified PnisA. Cell extracts from L. lactis
pNZ-RBS, pNZ-RBSpylTS, and pNZ-RBSpylTSnisA were applied to a
Streptactin column and the two elution fractions were analyzed by
immunoblotting with a Streptactin–HRP conjugate. Only cells expressing
PylRS led to detection by the antibody (upper picture). Strep-tagged Page
Ruler Standard (Thermo Fisher Scientific) served as positive control, apparent
molecular weight and calculated value for PylRS are indicated. The
corresponding 10% SDS-PAGE stained with Coomassie brilliant blue revealed
that all analyzed fractions contained protein (picture below).
the presence of BocK, documenting the functionality of the OTS
resulting in incorporation of BocK into GFP (Supplementary
Figure S1).
To determine if the same ncAA can also be incorporated
into nisin, gfp(amber) was replaced by nisA(amber). As target
locations in nisin, the codons for core peptide I4 and K12
were chosen, as they were promising candidates as indicated
by the E. coli experiments (see above). To synthesize the
variants and to purify them from the culture supernatant,
L. lactis NZ9000 transformed with pIL3EryBTC and pNZ-
RBSpylTSnisA(I4amber) or pNZ-RBSpylTSnisA(K12amber),
respectively, was cultivated. These strains express the transporter
NisT capable to transport nisin out of the cells, which enables
peptide purification from the culture supernatant. The nisin
variants remain inactive at this point, because no protease
is present to cleave off the leader peptide. The antimicrobial
activity of the supernatant of the corresponding cultures was
checked against the nisin-sensitive indicator strain L. lactis
FIGURE 4 | Antimicrobial activity of nisin variants produced in L. lactis.
Samples were tested for growth inhibition of the nisin-sensitive indicator strain
L. lactis NZ9000 pNZnisPT pIL253. The producer strains lack NisP, so that
produced nisin variants remain inactive since the leader peptide stays
attached. Upon addition of cell lysate or purified peptide samples to the
NisP-expressing indicator strain, active nisin can be liberated. (A) Control
samples: 30 µg pure nisin was used as positive control and pure CDM
medium as negative control. To exclude antimicrobial activity resulting from
PylRS–tRNAPyl expression or addition of 5 mM BocK to the medium, the
corresponding supernatant samples were tested separately and showed no
antimicrobial activity. (B) Comparison of antimicrobial activity of WT nisin and
nisin(BocK) variants produced in presence of different BocK concentrations.
The rising BocK concentrations did not affect the antimicrobial activity of nisin
WT. In the absence of BocK, expression of nisA(I4amber) or nisA(K12amber)
did not result in antimicrobial activity. Only upon addition of up to 5 mM BocK,
antimicrobial activity was observed, with 2 mM as optimal concentration.
NZ9000 pNZnisPT pIL253. By using this NisP producing
indicator strain, the leader peptide gets cleaved off, liberating
active nisin (Khusainov et al., 2011). As seen before for
samples purified from E. coli, only samples from production
cultures supplemented with BocK showed antimicrobial activity,
indicating that translation was terminated in absence of
ncAA supplementation and that no canonical amino acid was
incorporated instead. Three internal controls were utilized: cells
bearing pNZ-RBSpylTSnisA pIL3EryBTC served as positive
control to determine the influence of the rearranged promoter on
nisin WT production. Culture supernatant of these cells always
showed antimicrobial activity independent of BocK addition,
assuring the general functionality of the nisin production system.
Two internal negative controls were performed. Supernatant
of cells expressing only PylRS–tRNAPyl either in the presence
and absence of BocK never had any antimicrobial effect.
Consequently, antimicrobial activity was caused by the novel
nisin variants and not by the orthogonal tRNA synthetase–tRNA
pair or the supplemented ncAA (Figure 4).
For further proof of ncAA incorporation into nisin,
HPLC-purified nisin(BocK) samples were analyzed by
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MALDI-TOF mass spectrometry. These measurements revealed
that ncAA-modified nisin variants were synthesized at a very low
level with the correct molecular weight (Table 1). Surprisingly,
always a mixed population of full-size nisin(BocK) samples was
determined: a larger one without His-tag and a smaller one
with His-tag was found (data not shown). In the chosen genetic
setup, the nisA reading frame starts with the ATG start codon
of the N-terminal His-tag and contains a second, internal ATG
codon originating from the first methionine of the leader, so
two peptide variants (resulting from two different translation
initiation sites) are possible. Selection of the untagged variant
by the chosen purification method, differing stabilities of His-
tagged and untagged variant or different folding of the peptide
variants during biosynthesis in L. lactis are possible explanations
for this phenomenon. Additionally, for nisin(I4BocK) and
nisin(K12BocK), peaks corresponding to different dehydration
states of the peptide were identified. Still, the main detected
dehydration state corresponds to a nisin molecule with two
or three rings, which explains the observed antimicrobial
activity (Rink et al., 2007). As control, HPLC-purified peptide
samples from cells grown without ncAA supplementation were
utilized. As expected, MALDI-TOF analysis showed no peaks
corresponding to full-size peptide products for this control
(Figure 5).
Expression of nisA(amber) in the
Presence of Different Concentrations of
BocK
To elaborate if increased ncAA concentrations can improve
the production of nisin(BocK) variants, L. lactis cultures were
supplemented with 0, 1, 2, and 5 mM BocK. As expected, the
antimicrobial activity of WT nisin was not influenced by different
BocK concentrations. Interestingly, for all tested nisin(BocK)
variants, 2 mM BocK delivered the highest antimicrobial activity.
Again, MALDI-TOF analysis confirmed the correct peptide mass
(compare Figure 5). In conclusion, incorporation of ncAAs into
nisin with L. lactis as expression host is possible and highly
specific. Still, the in vivo synthesized amount of the ncAA-
modified RiPP variants needs further improvement. Despite the
low peptide yields, we could demonstrate the functional transfer
TABLE 1 | Determination of the molecular weight of WT and nisin(BocK) variants
produced in L. lactis by MALDI–TOF–MS.
Nisin variant Modification∗ Predicted mass (Da) Observed mass (Da)
Nisin WT –8 H2O, –M 5585.69 5588.92
Nisin(I4BocK) –8 H2O, –M 5718.75 5714.67
–7 H2O, –M 5736.75 5735.2
Nisin(K12BocK) –8 H2O, –M 5784.81 5780.56
–7 H2O, –M 5802.81 5795.71
–6 H2O, –M 5820.81 5816.49
–5 H2O, –M 5838.81 5841.59
–4 H2O, –M 5856.81 5857.97
–2 H2O, –M 5892.81 5885.54
∗–M, removal of the N-terminal initiator methionine residue.
FIGURE 5 | HPLC purification of nisin(K12BocK) (red) produced in L. lactis
and the corresponding control produced in the absence of BocK
supplementation nisin(K12amber) (blue). (A) Comparing the elution
chromatograms, the most interesting peak at 22 min is zoomed in (gray
shading). Only if BocK was available in the growth medium, the highlighted
peak was detectable. In contrast, no peak was visible for the control which
lacks BocK supplementation (blue), indicating that no full-size peptide was
synthesized. (B) MALDI–TOF–MS analysis of the samples above picture
exemplary for all other measurements described in Table 1. For
nisin(K12BocK), several different dehydration variants were detected. The
most prominent signal at m/z = 5857.97 indicates a nisin variant with only four
dehydrations. Depending on the location of the dehydrated serines and
threonines, the formation of the first two or three rings is still possible, resulting
in antimicrobial activity of the variants.
of the PylRS-based SCS machinery to the Gram-positive host
L. lactis.
DISCUSSION
In this study, we established genetic code expansion of L. lactis
by functional expression of an OTS based on PylRS–tRNAPyl.
The successful combination of SCS and PTM enzymes led to the
production of bioactive BocK-modified nisin variants. To identify
the ideal host for genetic code expansion and post-translationally
modified lantibiotic production, we tested two expression hosts:
E. coli and L. lactis, because each of them has distinct advantages.
Since SCS represents a method predominantly described
for E. coli strains with single (Wang et al., 2001) or multiple
ncAA incorporation and with PylRS expression adopted to this
expression host (Sugawara and Nikaido, 2014; Baumann et al.,
2018), it was at first glance the promising host of choice for
realizing ncAA-modified nisin. Additionally, in-depth analysis of
PylRS–tRNAPyl expression in E. coli revealed CUA as the ideal
tRNAPyl anticodon for ribosomal incorporation of BocK into
growing polypeptide chains (Odoi et al., 2013). The production
of post-translationally modified active nisin in E. coli was already
documented several times (Shi et al., 2011; Baumann et al., 2017).
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Moreover, the type II lantibiotic haloduracin was expressed
with the required PTM enzymes and in parallel, p-benzoyl-
L-phenylalanine was incorporated by SCS (Shi et al., 2011).
Recently, the first SCS approach with nisin in E. coli was
documented (Zambaldo et al., 2017). In contrast to our general
approach which aimed to find the optimal ncAA location
resulting in the highest antimicrobial activity, the latter focused
only on certain selected serine positions. Aiming for the
construction of new ring topologies, these serines were replaced
by phenylalanine analogs. However, this did not yield bioactive
molecules. In our case, the obtained new-to-nature nisin(BocK)
variants were bioactive and modified by both the ncAA and the
natural PTM machinery.
Due to the complexity of the methodology, also the challenges
of this method were analyzed in depth in E. coli. Previous
studies gave insights into possible reasons for low production
yields using an OTS: The kinetics of amino acid activation and
tRNA charging by PylRS gave information about the efficacy of
the enzyme. Relative to canonical aminoacyl tRNA synthetases,
its kcat values are about 1000 times lower. In the natural
context, this turnover rate of the enzyme is sufficient, since
in Methanosarcina only around 50 Pyl (amber) codons are
found in all transcribed genes. In contrast, in E. coli the leucyl-
tRNA synthetase needs to provide substrates for approximately
150,000 codons. Relative to the already low efficiencies for the
WT substrate Pyl, variants engineered for ncAA incorporation
commonly perform worse (Guo et al., 2014). Certainly, SCS
brings along a reduction in RiPP production yields, since five
recombinant genes of different origins have to be expressed: pylTS
from archaeal alongside nisABC from Gram-positive origin, all
in a Gram-negative host organism. Combined with the metabolic
burden to maintain the corresponding plasmids, this illustrates
the challenge of combining SCS with RiPP synthesis (Ow et al.,
2006).
Since nisABTC originate from L. lactis and most lantibiotics
are originally synthetized by Gram-positive bacteria (Dischinger
et al., 2014), L. lactis as expression host for PylRS–tRNAPyl
represented a logical step. This is supported by previous studies,
which demonstrated that L. lactis is a good candidate for
orthogonal expression of functional modification enzymes, e.g.,
GdmD of Staphylococcus gallinarum (van Heel et al., 2013).
This illustrates the high combinatorial possibilities of different
PTMs in these organisms and their potential for synthesis of
new antibiotics (Montalbán-López et al., 2017). With PylRS–
tRNAPyl, we expressed for the first time a tRNA synthetase
with its cognate tRNA of archaeal origin in L. lactis. The
functionality of this orthogonal pair in this host could also
be shown in combination with the NisBTC nisin modification
enzymes, leading to PTM of the ncAA-modified nisin precursor
and transport out of the cell into the culture supernatant.
The high substrate tolerance of the NisBTC system allows
modification not only of RiPPs from different origins (van Heel
et al., 2016), but also of the newly synthesized nisin(BocK)
variants. With our results for L. lactis and previous works on
B. cereus (Luo et al., 2016) and Streptomyces albus (Lopatniuk
et al., 2017), SCS has now been successfully implemented
in three Gram-positive organisms from different prokaryotic
families. In all three cases, expression of an OTS was successfully
combined with the natural PTM enzymes for either nisin
(current study), thiocillin (Luo et al., 2016), or cinnamycin
(Lopatniuk et al., 2017) of the expression host. These findings
indicate the potential of Gram positives as production hosts
for new peptide antibiotics. Concerning the location of ncAA
incorporation, especially nisinK12 represents an interesting
position for mutagenesis. In accordance with our data, previous
studies revealed that replacement of K12 by alanine, serine, or
threonine improves the antimicrobial activity of nisin against
diverse pathogens, e.g., Enterococcus faecalis, B. cereus, and
S. aureus (Molloy et al., 2013). The antimicrobial activity depends
on the chemistry of the chosen amino acids, since replacement
of K12 by aspartate combined with four other replacements of
amino acids by negatively charged ones led to a tremendous
decrease of the antimicrobial activity (Khusainov and Kuipers,
2013).
The possibility to combine PTM and SCS, either in E. coli
or in L. lactis, is good news for the development of new
antimicrobials, since it allows researchers to benefit from several
advantages. For both organisms, high- and low-copy vectors with
inducible and constitutive promoters are available, allowing fast
construction of the aimed construct and a high combinatorial
potential (Baumann et al., 2017). A short generation time allows
fast experiments and fast results. In special cases, sophisticated
expression setups even allow production to outcompete the
natural host (Kunji et al., 2003; Sezonov et al., 2007; Ongey and
Neubauer, 2016).
In comparative experiments using both bacterial hosts,
currently, E. coli is still the preferable host, benefitting from
years of SCS optimization. However, this can be changed
in future given that the OTS efficiency in L. lactis can be
optimized. As for the sophisticated E. coli systems which still
hold room for optimization (Zheng et al., 2016), the genetic
setup for the archaeal tRNA and its amino acyl tRNA synthetase
expression certainly requires fine-tuning and balancing with the
three nisin production genes. For example, in E. coli, pylTS
were expressed constitutively and only nisABC expression was
regulated by the inducible T7 promoter. This potentially led to
a higher production yield of nisin(I4BocK) and nisin(K12BocK)
in E. coli than in L. lactis. Additionally, the mass spectrometry
data suggest a main population of fully post-translationally
modified nisin variants in contrast to the mixed dehydration
status resulting from L. lactis cultivation. In the latter host,
the expression of pylTS as well as nisABTC was regulated by
a PnisA promoter, a method optimized for RiPP synthesis in
L. lactis. Therefore, different promoter setups and gene copy
numbers for pylTS as well as RBS and codon optimization of
pylS, which originates from a genetically distant archaeal host,
are conceivable options. In previous works on B. cereus, the
expression of the orthogonal tRNA was driven by host cell tRNA
promoters – a promising setup to be tested using L. lactis (Luo
et al., 2016).
Additional approaches to further improve the target
production and OTS performance can be followed in both
hosts: Besides improving the aminoacyl-tRNA synthetase
efficiency, rational (re)design of orthogonal tRNAs can allow
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for more efficient ncAA incorporation (Fan et al., 2015;
Maranhao and Ellington, 2017). Genome engineering can allow
the knockout of RF-1, which otherwise competes with amber
suppressors and leads to translation termination. Accordingly,
the resulting E. coli K and B strains can enable efficient and
multi-site ncAA incorporation (Mukai et al., 2015; Zheng et al.,
2016). Moreover, elongation factor Tu (EF-Tu; which delivers the
aminoacyl-tRNAs to the ribosome) and other parts the ribosomal
machinery can be engineered (Mukai et al., 2017). Little is known
about stop codon suppressor mutants in L. lactis. Only one
instance of an amber suppressor was reported so far (Dickely
et al., 1995). This unwanted mutation can in our experiments be
excluded by the obtained mass spectrometry data. Additionally,
with the first documented OTS shuttle vector system for E. coli,
Salmonella enterica, and Vibrio cholerae, new developments also
for Gram-positive species are expected in the long run (Volkwein
et al., 2017).
Clearly, the prospects are as big as the challenges. Recent
reviews highlight the strong pharmaceutical potential of
ncAA-supplemented drugs against various pathogens, e.g.,
MRSA, Acinetobacter baumannii, C. difficile, and Pseudomonas
aeruginosa (Blaskovich, 2016; Hicks, 2016; Wang et al., 2016;
Baumann et al., 2017). The modification of AMPs with new-
to-nature ncAAs presents a versatile tool to fight the increasing
lack of antimicrobial drugs (Blaskovich, 2016; Baumann et al.,
2017). As the next stage, synthetic cells metabolically engineered
to produce ncAAs in situ from simple chemical precursors
are highly promising, especially for large-scale fermentation
in industrial biotechnology (Völler and Budisa, 2017). Genetic
code engineering and expansion complement traditional gene
modification technologies, breaking the limitations in the
number of building blocks and chemical diversity. This synthetic
co-translational modification in combination with natural PTM
machineries from diverse sources will become the method of
choice to synthesize RiPP-based derivatives with novel and
emergent properties.
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